{"id":"W4392284387","doi":"10.1016/j.jaci.2024.01.028","title":"Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials","year":2024,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"Regeneron Pharmaceuticals; Sanofi; Amgen; Celldex Therapeutics; Genentech; AstraZeneca","keywords":"Placebo; Dupilumab; Chronic urticaria; Medicine; Double blind; Randomized controlled trial; Phase (matter); Dermatology; Internal medicine; Alternative medicine; Atopic dermatitis; Pathology; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002895834,0.0002759206,0.002769544,0.0004118852,0.00007739226,0.00005867063,0.0001451713,0.0004636551,0.0006639127],"category_scores_gemma":[0.001207851,0.0001546311,0.0007992533,0.0002255103,0.0005703096,0.0001619659,0.00004572357,0.001689321,0.00003744187],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001151949,"about_ca_system_score_gemma":0.0006980209,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002548748,"about_ca_topic_score_gemma":0.00008032031,"domain_scores_codex":[0.9950809,0.001066812,0.002886118,0.0003137527,0.0002808289,0.0003715289],"domain_scores_gemma":[0.9944057,0.00424636,0.0006255748,0.000242106,0.0002590451,0.0002211517],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9520836,0.001749162,0.0001850696,0.000008395357,0.03388453,0.002958999,0.0001214721,0.00002790941,0.00006524314,0.002907159,0.0001386769,0.005869727],"study_design_scores_gemma":[0.9773306,0.006971664,0.0008824342,0.0004594896,0.008788582,0.002350762,0.00004258759,0.0005626709,0.00001283506,0.0008908208,0.001526701,0.0001808489],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810272,0.01161676,0.0002543896,0.003094218,0.001758264,0.001279663,0.000004699857,0.0000308004,0.0009339571],"genre_scores_gemma":[0.9917057,0.006553898,0.0001588698,0.0001871109,0.0005856752,0.00003926695,0.00002189604,0.00003463683,0.0007130041],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02524695,"threshold_uncertainty_score":0.7339354,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02650355750841208,"score_gpt":0.3545363251829817,"score_spread":0.3280327676745696,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}